Basic Information
NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV
INJECTION, SUSPENSION
Regulatory Information
SIN17148P
December 16, 2024
Prescription Only
Therapeutic
INTRAMUSCULAR
May 23, 2025
June 4, 2025
Company Information
PE PHARMA PTE LTD
Active Ingredients
SARS-CoV-2 recombinant spike protein (Omicron JN.1)
Strength: 5 mcg/dose